on Bayer Aktiengesellschaft (ETR:BAYN)
Bayer Adjusts Financial Guidance and Litigation Provisions for 2025
On July 31, 2025, Bayer AG announced an update to its financial projections for the year, ahead of its second-quarter results. The company has raised its currency-adjusted sales forecast to 46-48 billion euros and expects EBITDA before special items to be between 9.7 and 10.2 billion euros. Core earnings per share predictions have also increased, now estimated at 4.80 to 5.30 euros.
Bayer has also made significant legal provisions, particularly regarding the Roundup™ litigation in the US, setting aside an additional 1.2 billion euros. This decision impacts the company's overall special items, now forecasted at minus 3.5 to minus 2.5 billion euros for the whole year. Bayer aims to resolve most of its US litigation by the end of 2026.
The company continues to monitor geopolitical impacts, notably tariffs that might influence its financial outlook. Full second-quarter results will be released on August 6, 2025.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Bayer Aktiengesellschaft news